Target type: molecularfunction
Enables the transfer of L-kynurenine from one side of a membrane to the other. [PMID:35245456]
L-kynurenine transmembrane transporter activity refers to the process by which a specific protein facilitates the movement of L-kynurenine across cell membranes. L-kynurenine is an important metabolic intermediate in the tryptophan pathway, which plays a significant role in various physiological processes. This transport activity is crucial for maintaining appropriate levels of L-kynurenine within and outside cells.
L-kynurenine transmembrane transporters are integral membrane proteins that possess a specific binding site for L-kynurenine. This binding site allows L-kynurenine to interact with the transporter protein, triggering a conformational change that facilitates its passage across the membrane. The movement of L-kynurenine can occur either with or against its concentration gradient, depending on the specific transporter and the energy source available.
The molecular function of L-kynurenine transmembrane transporter activity can be further elaborated as follows:
- **Substrate Specificity:** These transporters exhibit high specificity for L-kynurenine, distinguishing it from other structurally similar molecules. This selectivity ensures that only L-kynurenine is transported, maintaining proper intracellular concentrations.
- **Transport Mechanism:** The transport process can involve either passive diffusion or active transport. Passive diffusion relies on the concentration gradient of L-kynurenine, while active transport requires energy expenditure to move L-kynurenine against its concentration gradient.
- **Regulation:** The activity of L-kynurenine transmembrane transporters can be regulated by various factors, including substrate concentration, cellular signaling pathways, and environmental cues. This regulation ensures that L-kynurenine transport is tightly controlled to meet the specific needs of the cell.
In summary, L-kynurenine transmembrane transporter activity plays a vital role in regulating L-kynurenine levels within and outside cells. This activity is crucial for maintaining proper cellular function and influencing various physiological processes related to the tryptophan pathway.'
"
Protein | Definition | Taxonomy |
---|---|---|
Cystine/glutamate transporter | A cystine/glutamate transporter that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q9UPY5] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
mesalamine | mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position. Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed) | amino acid; aromatic amine; monocarboxylic acid; monohydroxybenzoic acid; phenols | non-steroidal anti-inflammatory drug |
sulfapyridine | sulfapyridine : A sulfonamide consisting of pyridine with a 4-aminobenzenesulfonamido group at the 2-position. Sulfapyridine: Antibacterial, potentially toxic, used to treat certain skin diseases. | pyridines; substituted aniline; sulfonamide; sulfonamide antibiotic | antiinfective agent; dermatologic drug; drug allergen; environmental contaminant; xenobiotic |
sulfasalazine | sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position. Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907) | ||
cysteine | cysteine; cysteine zwitterion; L-alpha-amino acid; proteinogenic amino acid; serine family amino acid | EC 4.3.1.3 (histidine ammonia-lyase) inhibitor; flour treatment agent; human metabolite | |
quisqualic acid | Quisqualic Acid: An agonist at two subsets of excitatory amino acid receptors, ionotropic receptors that directly control membrane channels and metabotropic receptors that indirectly mediate calcium mobilization from intracellular stores. The compound is obtained from the seeds and fruit of Quisqualis chinensis. | non-proteinogenic alpha-amino acid | |
serine o-sulfate | L-serine O-sulfate : A non-proteinogenic L-alpha-amino acid that is the O-sulfo derivative of L-serine. serine O-sulfate: RN given refers to (L)-isomer | L-serine derivative; non-proteinogenic L-alpha-amino acid; O-sulfoamino acid | |
homocysteic acid | homocysteic acid : A non-proteinogenic alpha-amino acid that is homocysteine in which the thiol group has benn oxidised to the corresponding sulfonic acid. homocysteic acid: promotes growth in hypophysectomized rats; RN given refers to parent cpd L-homocysteic acid : A homocysteic acid with L-configuration. | homocysteic acid | NMDA receptor agonist |
susalimod | susalimod: analogue of sulphasalazine, was designed for use in the treatment of rheumatoid arthritis | ||
erastin | erastin : A member of the class of quinazolines that is quinazolin-4(3H)-one in which the hydrogens at positions 2 and 3 are replaced by 1-{4-[(4-chlorophenoxy)acetyl]piperazin-1-yl}ethyl and 2-ethoxyphenyl groups, respectively. It is an inhibitor of voltage-dependent anion-selective channels (VDAC2 and VDAC3) and a potent ferroptosis inducer. erastin: an antineoplastic agent; structure in first source | aromatic ether; diether; monochlorobenzenes; N-acylpiperazine; N-alkylpiperazine; quinazolines; tertiary carboxamide | antineoplastic agent; ferroptosis inducer; voltage-dependent anion channel inhibitor |